DE69928524D1 - Biologisch aktive zusammensetzung - Google Patents

Biologisch aktive zusammensetzung

Info

Publication number
DE69928524D1
DE69928524D1 DE69928524T DE69928524T DE69928524D1 DE 69928524 D1 DE69928524 D1 DE 69928524D1 DE 69928524 T DE69928524 T DE 69928524T DE 69928524 T DE69928524 T DE 69928524T DE 69928524 D1 DE69928524 D1 DE 69928524D1
Authority
DE
Germany
Prior art keywords
biologically active
active agent
carrier
active composition
biological active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69928524T
Other languages
English (en)
Other versions
DE69928524T2 (de
Inventor
Ke Lindahl
H Kan Hagslaett
Catharina Heiman
Rickard Bryland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Bioglan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan AB filed Critical Bioglan AB
Publication of DE69928524D1 publication Critical patent/DE69928524D1/de
Application granted granted Critical
Publication of DE69928524T2 publication Critical patent/DE69928524T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69928524T 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung Expired - Lifetime DE69928524T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
SE9801704 1998-05-14
PCT/SE1999/000823 WO1999058108A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (2)

Publication Number Publication Date
DE69928524D1 true DE69928524D1 (de) 2005-12-29
DE69928524T2 DE69928524T2 (de) 2006-08-10

Family

ID=20411318

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69928524T Expired - Lifetime DE69928524T2 (de) 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung
DE1082102T Pending DE1082102T1 (de) 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1082102T Pending DE1082102T1 (de) 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung

Country Status (20)

Country Link
US (1) US6537576B1 (de)
EP (1) EP1082102B1 (de)
JP (1) JP2002514587A (de)
KR (1) KR100592971B1 (de)
CN (1) CN1309553A (de)
AT (1) ATE310500T1 (de)
AU (1) AU736480B2 (de)
CA (1) CA2331527C (de)
DE (2) DE69928524T2 (de)
ES (1) ES2155048T3 (de)
GR (1) GR20010300013T1 (de)
HU (1) HUP0102426A2 (de)
IL (2) IL139576A0 (de)
NO (1) NO20005724L (de)
NZ (1) NZ508073A (de)
PL (1) PL344051A1 (de)
SE (1) SE9801704D0 (de)
TR (1) TR200003589T2 (de)
WO (1) WO1999058108A1 (de)
ZA (1) ZA200006474B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
US8431140B2 (en) * 2006-06-14 2013-04-30 Dr. Reddy's Laboratories, Inc. Topical compositions
US20080226698A1 (en) 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
JP2012504609A (ja) * 2008-10-06 2012-02-23 マイラン・テクノロジーズ，インコーポレイテッド アモルファスロチゴチン経皮システム
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
KR102377252B1 (ko) 2013-02-28 2022-03-22 저니 메디컬 코퍼레이션 글리코피롤레이트 염

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD217989A1 (de) 1983-08-09 1985-01-30 Univ Ernst Moritz Arndt Verfahren zur herstellung einer pharmazeutischen zubereitung
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
AR246186A1 (es) 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
AU4405099A (en) 1999-11-29
PL344051A1 (en) 2001-09-24
KR100592971B1 (ko) 2006-06-23
JP2002514587A (ja) 2002-05-21
ZA200006474B (en) 2001-09-04
NZ508073A (en) 2002-12-20
WO1999058108A1 (en) 1999-11-18
IL139576A0 (en) 2002-02-10
ES2155048T3 (es) 2006-06-16
CA2331527A1 (en) 1999-11-18
NO20005724L (no) 2001-01-09
DE1082102T1 (de) 2001-09-06
HUP0102426A2 (hu) 2002-03-28
SE9801704D0 (sv) 1998-05-14
GR20010300013T1 (en) 2001-04-30
ATE310500T1 (de) 2005-12-15
IL139576A (en) 2007-07-04
NO20005724D0 (no) 2000-11-13
US6537576B1 (en) 2003-03-25
EP1082102A1 (de) 2001-03-14
KR20010052348A (ko) 2001-06-25
CA2331527C (en) 2010-04-13
EP1082102B1 (de) 2005-11-23
ES2155048T1 (es) 2001-05-01
TR200003589T2 (tr) 2001-03-21
DE69928524T2 (de) 2006-08-10
CN1309553A (zh) 2001-08-22
AU736480B2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
DE69033994T2 (de) Flüssige Polymerzusammensetzung und Verfahren zu ihrer Verwendung
JPS57192463A (en) Polymer film having maleic anhydride residue
RS49995B (sr) Primena dialkil fumarata
BR9609033A (pt) Sistema de liberação controlada de líquido de alta viscosidade.
JPS5548392A (en) Novel immobilizing material combined with biologically active substance, its preparation, device comprising it, method, and preparation of support
TR199900353T2 (xx) Kontroll� salma sa�layan cihazlar�n yap�m� i�in y�ntem.
BR0011380A (pt) Processos para intensificar a biodegradabilidade de um artigo moldado e de um filme polimérico
NO954957D0 (no) Synergistisk stabiliserte flytende enzymatiske blandinger
DE69928524D1 (de) Biologisch aktive zusammensetzung
DE50004443D1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
DE69829570D1 (de) Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung
AU5071199A (en) Process for the treatment of waste water containing specific components, e.g. ammonia
NO20005725D0 (no) Biologisk aktiv sammensetning
DE69927669D1 (de) Für reduzierende bedingungen empfindliche transfektions-verbindungen, pharmazeutische zusammensezungen die diese enthalten und deren verwendung.
JPS5687519A (en) Drug pharmaceutical
Haller Enhanced biological phosphorus removal.
Pagga Biodegradation of Substances at Low Concentrations(Biologischer Abbau von Stoffen bei Geringen Konzentrationen)
RU96102520A (ru) Способ обработки скважины
Sadecka Wplyw wybranych pestycydow na proces fermentacji metanowej.
KR930012035A (ko) 소마토트로핀을 함유하는 지속성 조성물
TH18948A (th) สารผสมสำหรับซักฟอก
KR830007470A (ko) 활성무기 식물영양제(活性無機植物營養劑)

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: JAGOTEC AG, MUTTENZ, CH

8364 No opposition during term of opposition